Get startedLog in
    Picture of SCHOTT Pharma AG & Co. KGaA logo

    1SXP — SCHOTT Pharma AG & Co. KGaA News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Schott Pharma AG & Co. KGaA See FY 25 Impacted By Slower Growth From Syringes

    Picture of SCHOTT Pharma AG & Co. KGaA logoSCHOTT Pharma AG & Co. KGaA
    14/05/2024 17:08
    May 14 (Reuters) - SCHOTT Pharma AG & Co KgaA  1SXP.DE :
    * EQS-ADHOC: SCHOTT PHARMA AG & CO. KGAA: SCHOTT PHARMA SEE
FY 25
IMPACTED BY SLOWER GROWTH FROM SYRINGES
    * COMPANY ALSO CONFIRMS ITS FORECAST FOR CURRENT FISCAL
YEAR.
    * CONFIRMS ITS MID-TERM FORECAST
    * FOR FISCAL YEAR 2024/2025 EBITDA MARGIN EXPANSION WILL BE
WEAKER
THAN CURRENTLY EXPECTED IN MARKET

Source text for Eikon:  ID:nEQ1QddBxa 
Further company coverage:  1SXP.DE 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on SCHOTT Pharma AG & Co. KGaA

    See all news